申请人:Pfizer Inc.
公开号:US07964732B2
公开(公告)日:2011-06-21
This invention provides a compound of the formula
These compounds are useful for the treatment of disease conditions caused by overactivation of the VR1 receptor such as pain, or the like in mammal. This invention also provides a pharmaceutical composition comprising the above compound.
这项发明提供了一个公式的化合物。这些化合物对于治疗由VR1受体过度激活引起的疾病状况,例如哪些在哺乳动物中引起疼痛等方面是有用的。该发明还提供了包括上述化合物的制药组合物。